Executive summary of the DAROC clinical practice guidelines for diabetes care-2018 Diabetes Association of the Republic of China (Taiwan)

doi:10.1016/j.jfma.2019.02.016

中山醫學大學機構典藏 CSMUIR > 中山醫學大學研究成果 > 期刊論文 > Item 310902500/24943

Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/24943

Title:	Executive summary of the DAROC clinical practice guidelines for diabetes care-2018 Diabetes Association of the Republic of China (Taiwan)
Authors:	Chen, JF;Chen, HS;Chu, CH;Chuang, LM;Ho, LT;Hung, YJ;Kuo, CH;Li, HY;Lin, CH;Lin, KD;Lin, SY;Sheen, YJ;Sheu, WHH;Shin, SJ;Tsai, ST;Te Tu, S;Bai, CH;Chang, YC;Chang, TJ;Chang, CH;Chang, CJ;Chao, CC;Chen, CC;Chen, YL;Chong, K;Chuang, WL;Guo, LY;Hsieh, MC;Hsu, CC;Huang, LC;Huang, CN;Huang, YY;Hung, CS;Hung, WW;Hwu, CM;Jeng, JS;Jiang, YD;Juang, JMJ;Juang, JH;Kuo, CS;Kuo, JF;Kwok, CF;Lai, YC;Lee, MY;Lee, YJ;Lee, IT;Lee, CN;Lee, YT;Lee, TI;Lee, CH;Lin, LY;Lin, SD;Lin, KY;Lin, HJ;Lin, CH;Liu, CE;Lo, FS;Lu, CH;Lu, KC;Ma, WY;Ou, HY;Pei, D;Su, CC;Su, SL;Tan, ECH;Tien, KJ;Tsai, LK;Tseng, CH;Wang, JS;Weng, SF;Wu, WC;Yang, MC;Yang, YS;Yang, CH;Yang, WS;Yeh, JT;Yu, NC;Yu, TY
Keywords:	Diabetes care;Guideline;Clinical recommendations;Diabetes association of the Republic of China;Taiwan
Date:	2020
Issue Date:	2022-08-09T08:10:35Z (UTC)
Publisher:	ELSEVIER TAIWAN
ISSN:	0929-6646
Abstract:	It is estimated that there were 1.73-2.20 million people with diabetes in Taiwan in 2014-2015. The executive summary briefly introduced recommendations from the Diabetes Association of Republic of China (DAROC) clinical practice guidelines for diabetes care- 2018. We described the diagnostic criteria for diabetes, pre-diabetes and gestational diabetes, and the screening methods for diabetes in asymptomatic subjects. Treatment goals for adults with diabetes, older adults with diabetes, children and adolescents with type 1 diabetes, women with gestational diabetes and inpatients were recommended. For people with type 2 diabetes, we suggested an algorithm including lifestyle modification, weight control, as well as the consideration and selection of anti-diabetic medications. Besides, we also recommended laboratory tests for metabolic monitoring, examinations for the screening of diabetic complications and the suggested testing intervals for these tests and examinations. Copyright (C) 2019, Formosan Medical Association. Published by Elsevier Taiwan LLC.
URI:	http://dx.doi.org/10.1016/j.jfma.2019.02.016 https://www.webofscience.com/wos/woscc/full-record/WOS:000513851500003 https://ir.csmu.edu.tw:8080/handle/310902500/24943
Relation:	JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION ,2020 ,v119 ,issue 2 ,p577-586
Appears in Collections:	[中山醫學大學研究成果] 期刊論文

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	281	View/Open

Loading...